HITI
High Tide Inc.
HITI offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over HITI overall, supported by stronger modeled upside and stronger valuation.
HITI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
HITI's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
HITI PE Valuation
HITI has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
HITI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
HITI has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
HITI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.27 | -$0.22 |
| Q2 2026 | -$0.35 | -$0.30 |
| Q1 2026 | -$0.38 | -$0.36 |
| Q4 2025 | -$0.41 | -$0.41 |
| Q4 2024 | -$0.00 | +$0.37 |
| Q4 2023 | -$0.37 | +$0.38 |
| Q3 2023 | -$0.60 | -$0.31 |
| Q2 2023 | -$0.60 | -$0.32 |
HITI is still losing money, but far less than before: $0.27 per share over the past year, against $1.38 at its worst in early 2020.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over HITI on earnings quality, reporting a profit while its opponent remains loss making.
HITI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $141.3M | +34% |
| Q2 2026 | $126.1M | +30% |
| Q1 2026 | $125.6M | +25% |
| Q4 2025 | $115.3M | +19% |
| Q3 2025 | $105.2M | +14% |
| Q2 2025 | $96.9M | +11% |
| Q1 2025 | $100.2M | +11% |
| Q4 2024 | $97.2M | +8.8% |
HITI has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.3% | +1.8 points |
| Q2 2026 | 4.5% | +3.8 points |
| Q1 2026 | 2.3% | +2.3 points |
| Q4 2025 | -12% | -9.6 points |
| Q3 2025 | 2.5% | +0.2 points |
| Q2 2025 | 0.7% | -0.9 points |
| Q1 2025 | 0.1% | -2.1 points |
| Q4 2024 | -2% | N/A |
HITI's operating margin was 4.3% last quarter, up 1.8 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over HITI on profitability, with a higher operating margin.
HITI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.5M | +10% |
| Q2 2026 | $1.6M | -59% |
| Q1 2026 | $2.2M | +$3.7M |
| Q4 2025 | $812.7K | -85% |
| Q3 2025 | $5.9M | +206% |
| Q2 2025 | $4M | -46% |
| Q1 2025 | -$1.4M | -143% |
| Q4 2024 | $5.4M | +2.4% |
HITI still generates free cash flow, though less than at its 2024 peak: $11M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over HITI on cash flow, with more consistent year-over-year improvement.
HITI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.6% | +6.7M shares |
| 1 year | +6.8% | +6M shares |
| 3 years | +26% | +19.6M shares |
| 5 years | +96% | +46.2M shares |
| Available history | +672% | +82.3M shares |
HITI has 95M diluted shares, up 6.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
HITI hasn't bought back shares in the past year.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over HITI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
HITI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 17.4x | High |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 0.8x | Very low |
| Q3 2022 | 5.6x | High |
| Q2 2022 | 5.1x | High |
| Q1 2022 | 7.5x | High |
HITI's net debt is about 17 years of its operating earnings (EBITDA), up from less than a year a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over HITI on leverage, with a lower net debt burden relative to earnings.
HITI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.0 | Neutral |
| Stochastic | 59.7 | Neutral |
HITI's weekly RSI is 50 (neutral) and its Stochastic is 60 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
HITI PE vs Healthcare Sector
HITI has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
HITI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.61 | 4.2% below |
| 20 week MA | $2.46 | 1.6% above |
| 50 week MA | $2.46 | 1.6% above |
| 100 week MA | $2.59 | 3.5% below |
| 200 week MA | $2.20 | 14% above |
HITI's trend is mixed: it's above three of its five weekly moving averages, and 14% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over HITI on trend strength, trading above more of its moving averages.
HITI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $3.15 | $4.70 | +49% |
| 2022 | $4.70 | $1.43 | -70% |
| 2023 | $1.43 | $1.63 | +14% |
| 2024 | $1.63 | $3.05 | +87% |
| 2025 | $3.05 | $2.78 | -8.9% |
| 2026 YTD | $2.78 | $2.50 | -10% |
HITI has finished higher in three of the last five years. It's down 10% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over HITI on returns for 2026, with the stronger performance.